Partnership expands access to clinically proven esophageal protection for atrial fibrillation ablation across federal ...

Hexagon Robotics and Microsoft have formed a strategic partnership to advance the development and deployment of industrial humanoid robots powered by Physical AI. By combining Hexagon’s robotics, ...

The United States stands as the global hub of technological innovation, hosting some of the most influential Information ...

The new direct-to-consumer offering from MS NOW is being pitched as different from other subscription digital offerings, but it will include 24/7 access to the linear network. Announced at the Versant ...

Advanced Paste can now perform tasks using local AI models instead of connecting to the cloud. Advanced Paste can now perform tasks using local AI models instead of connecting to the cloud. is a news ...

TL;DR: Intel has hired TSMC's former Senior VP Wei-Jen Lo to lead advanced packaging efforts at its Arizona fab, targeting major US tech clients like NVIDIA, Tesla, Microsoft, and Qualcomm. This ...

Sophos, a global leader of innovative security solutions for defeating cyberattacks, today announced the general availability of new integrations that connect Sophos Intelix, its robust repository of ...

Lumen’s newest collaboration brings managed security expertise to Microsoft Sentinel to transform operations with network-driven intelligence from Black Lotus Labs® Lumen AMDR with Microsoft Sentinel ...

Microsoft will invest $15.2 billion in the United Arab Emirates over the next four years, the company announced Monday at the first annual Abu Dhabi Global AI Summit. The investment will include the ...

Microsoft saved its most powerful AI tools for paying customers in the first phase of its AI evolution. Now, the company has announced a series of Copilot features coming to all Windows 11 PCs, ...

Ocrelizumab (Ocrevus) delayed overall disability progression and worsening of upper limb function in people with primary progressive multiple sclerosis (PPMS) over 144 weeks, the ORATORIO-HAND (O'HAND ...

BARCELONA, Spain — A new phase 3 trial of ocrelizumab in primary progressive multiple sclerosis (PPMS) showed meaningful benefit in older patients and those with advanced disease — a first for this ...